These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13221268)

  • 21. A comparative study on the electrophoretic patterns of snake venoms.
    Tan NH; Ponnudurai G
    Comp Biochem Physiol B; 1992 May; 102(1):103-9. PubMed ID: 1526113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of the venom delivery system in Elapidae snake species: Naja siamensis and Oxyuranus microlepidotus.
    Logan JM; Beck A; Dunstan N; Allen L; Woods AE
    Toxicon; 2021 Aug; 199():12-19. PubMed ID: 34010665
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Snake alpha-neurotoxin binding site on the Egyptian cobra (Naja haje) nicotinic acetylcholine receptor Is conserved.
    Takacs Z; Wilhelmsen KC; Sorota S
    Mol Biol Evol; 2001 Sep; 18(9):1800-9. PubMed ID: 11504859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. North American coral snake antivenin for the neutralization of non-native elapid venoms in a murine model.
    Richardson WH; Tanen DA; Tong TC; Betten DP; Carstairs SD; Williams SR; Cantrell FL; Clark RF
    Acad Emerg Med; 2006 Feb; 13(2):121-6. PubMed ID: 16436788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of low molecular weight platelet aggregation inhibitors from snake venoms.
    Oyama E; Takahashi H
    Toxicon; 2007 Mar; 49(3):293-8. PubMed ID: 17141819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Growth inhibition of Trypanosoma cruzi and Leishmania donovani infantum by different snake venoms: preliminary identification of proteins from Cerastes cerastes venom which interact with the parasites.
    Fernandez-Gomez R; Zerrouk H; Sebti F; Loyens M; Benslimane A; Ouaissi MA
    Toxicon; 1994 Aug; 32(8):875-82. PubMed ID: 7985193
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular cloning of serine proteases from elapid snake venoms.
    Jin Y; Lee WH; Zhang Y
    Toxicon; 2007 Jun; 49(8):1200-7. PubMed ID: 17408712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole snake venoms: Cytotoxic, anti-metastatic and antiangiogenic properties.
    Kerkkamp H; Bagowski C; Kool J; van Soolingen B; Vonk FJ; Vlecken D
    Toxicon; 2018 Aug; 150():39-49. PubMed ID: 29763628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A three-compartment open pharmacokinetic model can explain variable toxicities of cobra venoms and their alpha toxins.
    Ismail M; Aly MH; Abd-Elsalam MA; Morad AM
    Toxicon; 1996 Sep; 34(9):1011-26. PubMed ID: 8896193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against Naja naja venom in dogs by hydrocortisone.
    MORALES F; ROOT HD; PERRY JF
    Proc Soc Exp Biol Med; 1961 Nov; 108():522-4. PubMed ID: 14475779
    [No Abstract]   [Full Text] [Related]  

  • 32. An efficient analytical platform for on-line microfluidic profiling of neuroactive snake venoms towards nicotinic receptor affinity.
    Heus F; Vonk F; Otvos RA; Bruyneel B; Smit AB; Lingeman H; Richardson M; Niessen WM; Kool J
    Toxicon; 2013 Jan; 61():112-24. PubMed ID: 23159399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ACTIVE IMMUNIZATION OF A HUMAN AGAINST NAJA NAJA VENOM. A PRELIMINARY REPORT. REP 594.
    FLOWERS HH
    Rep US Army Med Res Lab; 1963 Nov; ():1-5. PubMed ID: 14133524
    [No Abstract]   [Full Text] [Related]  

  • 34. A Simple and Novel Strategy for the Production of a Pan-specific Antiserum against Elapid Snakes of Asia.
    Ratanabanangkoon K; Tan KY; Eursakun S; Tan CH; Simsiriwong P; Pamornsakda T; Wiriyarat W; Klinpayom C; Tan NH
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004565. PubMed ID: 27058956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Snake bite in Nigeria.
    Habib AG; Gebi UI; Onyemelukwe GC
    Afr J Med Med Sci; 2001 Sep; 30(3):171-8. PubMed ID: 14510123
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative study of the cytolytic activity of snake venoms from African spitting cobras (Naja spp., Elapidae) and its neutralization by a polyspecific antivenom.
    Méndez I; Gutiérrez JM; Angulo Y; Calvete JJ; Lomonte B
    Toxicon; 2011 Nov; 58(6-7):558-64. PubMed ID: 21924279
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic peptide antigens derived from long-chain alpha-neurotoxins: Immunogenicity effect against elapid venoms.
    de la Rosa G; Pastor N; Alagón A; Corzo G
    Peptides; 2017 Feb; 88():80-86. PubMed ID: 28010961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of proteomic profiles of the venoms of two of the 'Big Four' snakes of India, the Indian cobra (Naja naja) and the common krait (Bungarus caeruleus), and analyses of their toxins.
    Choudhury M; McCleary RJR; Kesherwani M; Kini RM; Velmurugan D
    Toxicon; 2017 Sep; 135():33-42. PubMed ID: 28602829
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cross neutralisation of Southeast Asian cobra and krait venoms by Indian polyvalent antivenoms.
    Leong PK; Tan NH; Fung SY; Sim SM
    Trans R Soc Trop Med Hyg; 2012 Dec; 106(12):731-7. PubMed ID: 23062608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The toxicity and immunological properties of some sea-snake venoms with particular reference to that of Enhydrina schistosa.
    CAREY JE; WRIGHT EA
    Trans R Soc Trop Med Hyg; 1960 Jan; 54():50-67. PubMed ID: 13807689
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.